| ISIN | LU1773287583 |
|---|---|
| Valor Number | |
| Bloomberg Global ID | |
| Fund Name | Bellevue Digital Health Bellevue Funds (Lux) - Bellevue Digital Health HB EUR |
| Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
| Fund Provider | Bellevue Asset Management AG |
| Representative in Switzerland |
Waystone Fund Services (Switzerland) SA Lausanne Phone: 0041213111781 |
| Distributor(s) | |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The Sub-fund is an actively managed equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the sub-fund in a portfolio of carefully chosen shares and preference shares of companies in the medical technology industry or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. |
| Peculiarities |
| Current Price * | 119.00 EUR | 07.01.2026 |
|---|---|---|
| Previous Price * | 118.56 EUR | 06.01.2026 |
| 52 Week High * | 123.57 EUR | 19.02.2025 |
| 52 Week Low * | 96.90 EUR | 08.04.2025 |
| NAV * | 119.00 EUR | 07.01.2026 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 148,648,141 | |
| Unit/Share Assets *** | ||
| Trading Information SIX | ||
| YTD Performance | +5.71% |
31.12.2025 - 07.01.2026
31.12.2025 07.01.2026 |
|---|---|---|
| YTD Performance (in CHF) | +5.70% |
31.12.2025 - 07.01.2026
31.12.2025 07.01.2026 |
| 1 month | +1.90% |
08.12.2025 - 07.01.2026
08.12.2025 07.01.2026 |
| 3 months | +9.00% |
07.10.2025 - 07.01.2026
07.10.2025 07.01.2026 |
| 6 months | +5.34% |
07.07.2025 - 07.01.2026
07.07.2025 07.01.2026 |
| 1 year | +2.03% |
07.01.2025 - 07.01.2026
07.01.2025 07.01.2026 |
| 2 years | +10.23% |
08.01.2024 - 07.01.2026
08.01.2024 07.01.2026 |
| 3 years | -4.80% |
28.04.2023 - 07.01.2026
28.04.2023 07.01.2026 |
| 5 years | - | - |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insulet Corp | 6.93% | |
|---|---|---|
| Intuitive Surgical Inc | 5.56% | |
| Penumbra Inc | 5.56% | |
| DexCom Inc | 5.33% | |
| Globus Medical Inc Class A | 5.02% | |
| Natera Inc | 4.94% | |
| Veeva Systems Inc Class A | 4.49% | |
| PROCEPT BioRobotics Corp | 4.39% | |
| Abbott Laboratories | 4.38% | |
| TransMedics Group Inc | 4.20% | |
| Last data update | 30.11.2025 | |
| TER *** | 2.21% |
|---|---|
| TER date *** | 30.06.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.60% |
| Ongoing Charges *** | 2.20% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |